SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

New ‘life-changing’ asthma drug gets green light after rise in hospital admissions - A trial cut hospital admissions by 72 ...

Blue Cross Blue Shield is changing how some asthma injections are given, sparking concerns from doctors. Blue Cross Blue Shield (BCBS), under its parent company Health Care Service Corporation, is ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an eosinophilic phenotype, according to a press release from GSK.Depemokimab ...

An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first approved for treating asthma in 2021, but new research led by a University of ...

More must be done to ensure that asthma patients get access to cutting-edge treatments, experts have said, after research ...

An asthma medication coverage policy by Health Care Services Corp. and its Illinois health plans that may lead to more at-home self-injections is meeting resistance from allergists, patients and an ...

Blue Cross Blue Shield (BCBS), under its parent company Health Care Service Corporation, is changing how certain asthma injections are administered. Effective April 15, 2025, some patients will need ...